Breast cancer is the second most lethal cancer in women. (Lung cancer is the leading cancer killer in women.) The good news is that early detection and new treatments have improved survival rates. Unfortunately, women in lower social and economic groups still have significantly lower survival rates than women in higher groups.
Several factors are used to determine the risk for recurrence and the likelihood of successful treatment. They include:
Most oncologists now are thinking of breast cancer as at least four diseases based on endocrine features - luminal A, luminal B, Her2... Read more »
Q. I’ve been diagnosed with triple negative breast cancer. Is this a type of breast cancer like IDC or inflammatory breast cancer,... Read more »
In 1998 the surgeon told me he wanted to schedule a biopsy for inflammatory breast cancer (IBC). I was too numb to ask very many... Read more »
Here’s a theme I hear over and over again from women with breast cancer: “I’m afraid of what might happen next. I’m scared of... Read more »
Before trying to make sense of breast cancer prognosis, it's important to know the type of breast cancer you're dealing with. Then, visit... Read more »
Source: Breastcancer.org
To understand triple-negative breast cancer, it’s important to understand receptors, which are proteins found inside and on the surface of cells.... Read more »
Scientists have discovered a unique biomarker for triple-negative breast cancer that may one day allow women to receive a more targeted treatment. A... Read more »
A new study has found that the more times a woman gives birth, the greater her risk of developing triple-negative breast cancer. The study found that... Read more »
Source: Breastcancer.org
Triple-negative breast cancer is typically treated with a combination of therapies such as surgery, radiation therapy, and chemotherapy. Many women... Read more »
Source: Breastcancer.org
Anyone can get triple-negative breast cancer. However, researchers have found that it is more likely to affect: Younger people. Triple-negative... Read more »